Koyfin Home > Directory > Health Care > Intercept Pharmaceuticals > Price / Earnings (ntm)

Intercept Pharmaceuticals Price / Earnings (ntm) Chart (ICPT)

Intercept Pharmaceuticals annual/quarterly Price / Earnings (ntm) from 2020 to 2020. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
Other Valuation Metrics:
  • Intercept Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $1,549m a -95.52% decrease of -1,479m year over year
  • Intercept Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 94.51 a 86.66% increase of 81.90 year over year
  • Intercept Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $1,489m a -85.63% decrease of -1,275m year over year
View Chart On Koyfin